SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-084349
Filing Date
2021-06-23
Accepted
2021-06-23 06:03:18
Documents
16
Period of Report
2021-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120374d1_8k.htm   iXBRL 8-K 27499
2 EXHIBIT 99.1 tm2120374d1_ex99-1.htm EX-99.1 19034
3 EXHIBIT 99.2 tm2120374d1_ex99-2.htm EX-99.2 18954
7 GRAPHIC tm2120374d1_ex99-1img001.jpg GRAPHIC 16904
8 GRAPHIC tm2120374d1_ex99-2img001.jpg GRAPHIC 6470
  Complete submission text file 0001104659-21-084349.txt   285222

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qure-20210621.xsd EX-101.SCH 3184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20210621_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20210621_pre.xml EX-101.PRE 22709
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2120374d1_8k_htm.xml XML 3498
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 211037140
SIC: 2834 Pharmaceutical Preparations